Compare ENZN to:
After Hours: 10.168 N/A (N/A) 1:17pm ET
| Last Trade: | 10.17 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 10.37 |
| Open: | 10.26 |
| Bid: | N/A |
| Ask: | 10.55 x 400 |
| 1y Target Est: | 12.67 |
| Day's Range: | 10.12 - 10.37 |
|---|---|
| 52wk Range: | 4.37 - 10.80 |
| Volume: | 178,309 |
| Avg Vol (3m): | 694,342 |
| Market Cap: | 462.28M |
| P/E (ttm): | 598.24 |
| EPS (ttm): | 0.02 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 19 | Enzon Presents Data at 2009 EORTC MeetingBusiness Wire |
| Mon, Nov 16 | Enzon to Present Data at EORTC-NCI-AACRBusiness Wire |
| Fri, Nov 13 | Unique Strategy Generates Big Returns for BaupostIndie Research |
| Thu, Nov 12 | Watching Klarman's Latest Biotech PlayRealMoney by TheStreet.com |
| Thu, Nov 12 | ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExEDGAR Online |
| Mon, Nov 9 | ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Mon, Nov 9 | Enzon sells specialty drug business for $300MAP |
| Mon, Nov 9 | UPDATE - Enzon to sell specialty pharma unitat Reuters |
| Mon, Nov 9 | Enzon to sell specialty pharmaceuticals businessat MarketWatch |
| Mon, Nov 9 | Enzon Announces Agreement to Sell Specialty Pharmaceutical BusinessBusiness Wire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.